Research output per year
Research output per year
The University of Western Australia (M504), 35 Stirling Highway,
6009 Perth
Australia
Accepting PhD and other Higher Degree by Research Students. View current PhD/HDR research project opportunities at https://researchdegrees.uwa.edu.au/projects
PhD/HDR research projects available:
In low-grade serous ovarian carcinoma (LGSOC), my PhD projects include identifying synergistic drug combinations using high-throughput screening of FDA-approved agents, kinase inhibitors, and epigenetic modulators. I am also establishing preclinical models, including organoids and patient-derived xenografts (PDX), to evaluate repurposed drugs. Additionally, my comprehensive multiomics analysis has revealed actionable genomic alterations in patients with poor survival outcomes. My work on cellular stress signalling has identified AAMDC as a key driver of treatment resistance, with ongoing studies testing targeted agents to restore therapy sensitivity. I am also investigating novel surface proteins in ovarian cancer as potential therapeutic targets.
In breast cancer research, my projects will explore the molecular drivers of breast cancer in women with high and low mammographic density. Another key area involves integrating germline and somatic mutation testing in breast cancer patients to guide treatment decisions, identify high-risk predisposition mutations, and assess the feasibility of implementing Universal Genetic Testing in Western Australia.
Dr Dane Cheasley is a Senior Research Scientist specialising in multiomics and high-throughput drug screening, addressing critical clinical and biological challenges in rare and aggressive ovarian carcinomas.
With over 5.5 million in independent funding, Dane has secured several prestigious research grants, including an NHMRC Ideas Grant, an Ovarian Cancer Research Foundation Grant, the US Department of Defense Ovarian Cancer Award, and a Mid-Career Victorian Cancer Agency Fellowship. His research is dedicated to advancing diagnostics and treatment strategies to improve outcomes for women with low-grade serous ovarian carcinoma.
A recognised leader in the field, Dane actively contributes to both breast and ovarian cancer research. He is an invited member of the International Consortium for Low-Grade Serous Ovarian Cancer and serves as an ambassador for the Australian Gynaecological Cancer Foundation. His work focuses on refining diagnostic tools and driving personalised medicine approaches to improve outcomes for women affected by cancer.
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Cancer Research, PhD, The transcriptional regulation of intestinal stem cell genes, La Trobe University
Award Date: 1 May 2013
Genetics, 1st Class Honours, The transcriptional role of stem cell gene LGR5 in colorectal cancer development and cryptogenesis, La Trobe University
Award Date: 30 Oct 2008
Genetics & Microbiology, Bachelor of Biological Sciences
Award Date: 30 Oct 2007
Member, International Consortium for Low-Grade Serous Ovarian Cancer
1 Oct 2024 → …
Scientific Ambassador, Australian Gynecological Cancer Foundation
1 Jan 2021 → …
Honorary Fellow, University of Melbourne
1 Jun 2016 → …
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Data article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review